Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) reported no changes to its authorised or issued share capital for the month ended 31 July 2026, according to its latest filing with Hong Kong Exchanges and Clearing Ltd.

Authorised / Registered Capital • H shares: 95.14 million ordinary shares at RMB 1 par value; authorised capital unchanged at RMB 95.14 million. • A shares (Shanghai listing): 288.43 million ordinary shares at RMB 1 par value; authorised capital unchanged at RMB 288.43 million. • Total authorised capital at month-end: RMB 383.57 million.

Issued Shares and Treasury Position • H shares in issue remained at 95.14 million, with no treasury stock. • A shares totalled 288.43 million, comprising 287.05 million outstanding shares and 1.38 million held as treasury stock—unchanged versus the previous month.

Public Float Compliance Chunli Medical confirmed adherence to the Hong Kong Stock Exchange’s minimum public-float requirement, maintaining at least 5% free float for its H share class.

Capital-Raising Instruments The company reported no activity in share options, warrants, convertible securities, or other equity-linked instruments during the period.

Regulatory Confirmations Management affirmed that all statutory and listing rule obligations related to the company’s securities remain fully satisfied as of 31 July 2026.

Overall, the July report reflects continued stability in Chunli Medical’s capital structure, with steady share counts and full compliance with exchange requirements.